Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces
Background. Microbial biofilms form on central venous catheters and may be associated with systemic infections as well as decreased dialysis efficiency due to catheter thrombosis. The most widely used anticoagulant catheter lock solution in the US is sodium heparin. We have previously shown that sod...
Gespeichert in:
Veröffentlicht in: | Nephrology, dialysis, transplantation dialysis, transplantation, 2006-08, Vol.21 (8), p.2247-2255 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2255 |
---|---|
container_issue | 8 |
container_start_page | 2247 |
container_title | Nephrology, dialysis, transplantation |
container_volume | 21 |
creator | Shanks, Robert M. Q. Sargent, Jennifer L. Martinez, Raquel M. Graber, Martha L. O'Toole, George A. |
description | Background. Microbial biofilms form on central venous catheters and may be associated with systemic infections as well as decreased dialysis efficiency due to catheter thrombosis. The most widely used anticoagulant catheter lock solution in the US is sodium heparin. We have previously shown that sodium heparin in clinically relevant concentrations enhances Staphylococcus aureus biofilm formation. In the present study, we examine the effect of several alternative catheter lock solutions on in vitro biofilm formation by laboratory and clinical isolates of S. aureus and coagulase-negative staphylococci (CNS). Methods. Lepirudin, low molecular weight heparin, tissue plasminogen activator, sodium citrate, sodium citrate with gentamicin and sodium ethylene diamine tetra-acetic acid (EDTA) were assessed for their effect on biofilm formation on polystyrene, polyurethane and silicon elastomer. Results. Sodium citrate at concentrations above 0.5% efficiently inhibits biofilm formation and cell growth of S. aureus and Staphylococcus epidermidis. Subinhibitory concentrations of sodium citrate significantly stimulate biofilm formation in most tested S. aureus strains, but not in CNS strains. Sodium EDTA was effective in prevention of biofilm formation as was a combination of sodium citrate and gentamicin. Low molecular weight heparin stimulated biofilm formation of S. aureus, while lepirudin and tissue plasminogen activator had little effect on S. aureus biofilm formation. Conclusions. This in vitro study demonstrates that heparin alternatives, sodium citrate and sodium EDTA, can prevent the formation of S. aureus biofilms, suggesting that they may reduce the risk of biofilm-associated complications in indwelling catheters. This finding suggests a biological mechanism for the observed improvement in catheter-related outcomes in recent clinical comparisons of heparin and trisodium citrate as catheter locking solutions. A novel and potential clinically relevant finding of the present study is the observation that citrate at low levels strongly stimulates biofilm formation by S. aureus. |
doi_str_mv | 10.1093/ndt/gfl170 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19366915</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19366915</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-c167239406610c36179f88266492c95d825675bc7f76126be10b23df63e1738a3</originalsourceid><addsrcrecordid>eNpd0F1rFDEUgOEgFrut3vgDZBDshTA2J5mcTC5l6YdQKhQV8SZksomdNjPZJhmw_96UXSwIgUDOwyG8hLwF-gmo4qfzppz-9gEkfUFW0CFtGe_FS7KqQ2ipoOqQHOV8RylVTMpX5BAQmUSKK_JjbcqtKy41Idr7JsewlDHOuRlnHxY3W9fkYra3j3UcrTWhGcboxzA1PqbJPNmmHlNfy2ibvCRvrMuvyYE3Ibs3-_uYfD8_-7a-bK--XnxZf75qrQBeWgsoGVcdRQRqOYJUvu8ZYqeYVWLTM4FSDFZ6icBwcEAHxjceuQPJe8OPyclu7zbFh8XloqcxWxeCmV1csgbFERWICt__B-_ikub6N82gB9EpxSr6uEM2xZyT83qbxsmkRw1UP6XWNbXepa743X7jMkxu80z3bSv4sAcm13A-mdmO-dn1lFfWVdfu3JiL-_NvbtK9Rsml0Jc_f-mb2uma30h9wf8CsPWVkQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>218154992</pqid></control><display><type>article</type><title>Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Shanks, Robert M. Q. ; Sargent, Jennifer L. ; Martinez, Raquel M. ; Graber, Martha L. ; O'Toole, George A.</creator><creatorcontrib>Shanks, Robert M. Q. ; Sargent, Jennifer L. ; Martinez, Raquel M. ; Graber, Martha L. ; O'Toole, George A.</creatorcontrib><description>Background. Microbial biofilms form on central venous catheters and may be associated with systemic infections as well as decreased dialysis efficiency due to catheter thrombosis. The most widely used anticoagulant catheter lock solution in the US is sodium heparin. We have previously shown that sodium heparin in clinically relevant concentrations enhances Staphylococcus aureus biofilm formation. In the present study, we examine the effect of several alternative catheter lock solutions on in vitro biofilm formation by laboratory and clinical isolates of S. aureus and coagulase-negative staphylococci (CNS). Methods. Lepirudin, low molecular weight heparin, tissue plasminogen activator, sodium citrate, sodium citrate with gentamicin and sodium ethylene diamine tetra-acetic acid (EDTA) were assessed for their effect on biofilm formation on polystyrene, polyurethane and silicon elastomer. Results. Sodium citrate at concentrations above 0.5% efficiently inhibits biofilm formation and cell growth of S. aureus and Staphylococcus epidermidis. Subinhibitory concentrations of sodium citrate significantly stimulate biofilm formation in most tested S. aureus strains, but not in CNS strains. Sodium EDTA was effective in prevention of biofilm formation as was a combination of sodium citrate and gentamicin. Low molecular weight heparin stimulated biofilm formation of S. aureus, while lepirudin and tissue plasminogen activator had little effect on S. aureus biofilm formation. Conclusions. This in vitro study demonstrates that heparin alternatives, sodium citrate and sodium EDTA, can prevent the formation of S. aureus biofilms, suggesting that they may reduce the risk of biofilm-associated complications in indwelling catheters. This finding suggests a biological mechanism for the observed improvement in catheter-related outcomes in recent clinical comparisons of heparin and trisodium citrate as catheter locking solutions. A novel and potential clinically relevant finding of the present study is the observation that citrate at low levels strongly stimulates biofilm formation by S. aureus.</description><identifier>ISSN: 0931-0509</identifier><identifier>EISSN: 1460-2385</identifier><identifier>DOI: 10.1093/ndt/gfl170</identifier><identifier>PMID: 16627606</identifier><identifier>CODEN: NDTREA</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject><![CDATA[adherence ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; anticoagulant ; Anticoagulants - administration & dosage ; Anticoagulants - adverse effects ; Anticoagulants - pharmacology ; Bacteremia - etiology ; Bacteremia - prevention & control ; bacteria ; Bacterial Adhesion - drug effects ; biofilm ; Biofilms - drug effects ; Biological and medical sciences ; catheter lock ; Catheterization ; Catheters, Indwelling - adverse effects ; Catheters, Indwelling - microbiology ; Citrates - administration & dosage ; Citrates - adverse effects ; Citrates - pharmacology ; Dose-Response Relationship, Drug ; Edetic Acid - pharmacology ; Emergency and intensive care: renal failure. Dialysis management ; Equipment Contamination - prevention & control ; Gentamicins - administration & dosage ; Heparin, Low-Molecular-Weight - pharmacology ; Hirudins - pharmacology ; Intensive care medicine ; Kidneys ; Medical sciences ; Nephrology. Urinary tract diseases ; Pharmacology. Drug treatments ; Polystyrenes ; Polyurethanes ; Recombinant Proteins - pharmacology ; Silicone Elastomers ; Solutions - pharmacology ; Staphylococcus aureus ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - growth & development ; Staphylococcus epidermidis ; Staphylococcus epidermidis - drug effects ; Staphylococcus epidermidis - growth & development ; Tissue Plasminogen Activator - pharmacology ; Tumors of the urinary system]]></subject><ispartof>Nephrology, dialysis, transplantation, 2006-08, Vol.21 (8), p.2247-2255</ispartof><rights>2006 INIST-CNRS</rights><rights>Copyright Oxford Publishing Limited(England) Aug 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-c167239406610c36179f88266492c95d825675bc7f76126be10b23df63e1738a3</citedby><cites>FETCH-LOGICAL-c513t-c167239406610c36179f88266492c95d825675bc7f76126be10b23df63e1738a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18036064$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16627606$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shanks, Robert M. Q.</creatorcontrib><creatorcontrib>Sargent, Jennifer L.</creatorcontrib><creatorcontrib>Martinez, Raquel M.</creatorcontrib><creatorcontrib>Graber, Martha L.</creatorcontrib><creatorcontrib>O'Toole, George A.</creatorcontrib><title>Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces</title><title>Nephrology, dialysis, transplantation</title><addtitle>Nephrol. Dial. Transplant</addtitle><description>Background. Microbial biofilms form on central venous catheters and may be associated with systemic infections as well as decreased dialysis efficiency due to catheter thrombosis. The most widely used anticoagulant catheter lock solution in the US is sodium heparin. We have previously shown that sodium heparin in clinically relevant concentrations enhances Staphylococcus aureus biofilm formation. In the present study, we examine the effect of several alternative catheter lock solutions on in vitro biofilm formation by laboratory and clinical isolates of S. aureus and coagulase-negative staphylococci (CNS). Methods. Lepirudin, low molecular weight heparin, tissue plasminogen activator, sodium citrate, sodium citrate with gentamicin and sodium ethylene diamine tetra-acetic acid (EDTA) were assessed for their effect on biofilm formation on polystyrene, polyurethane and silicon elastomer. Results. Sodium citrate at concentrations above 0.5% efficiently inhibits biofilm formation and cell growth of S. aureus and Staphylococcus epidermidis. Subinhibitory concentrations of sodium citrate significantly stimulate biofilm formation in most tested S. aureus strains, but not in CNS strains. Sodium EDTA was effective in prevention of biofilm formation as was a combination of sodium citrate and gentamicin. Low molecular weight heparin stimulated biofilm formation of S. aureus, while lepirudin and tissue plasminogen activator had little effect on S. aureus biofilm formation. Conclusions. This in vitro study demonstrates that heparin alternatives, sodium citrate and sodium EDTA, can prevent the formation of S. aureus biofilms, suggesting that they may reduce the risk of biofilm-associated complications in indwelling catheters. This finding suggests a biological mechanism for the observed improvement in catheter-related outcomes in recent clinical comparisons of heparin and trisodium citrate as catheter locking solutions. A novel and potential clinically relevant finding of the present study is the observation that citrate at low levels strongly stimulates biofilm formation by S. aureus.</description><subject>adherence</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>anticoagulant</subject><subject>Anticoagulants - administration & dosage</subject><subject>Anticoagulants - adverse effects</subject><subject>Anticoagulants - pharmacology</subject><subject>Bacteremia - etiology</subject><subject>Bacteremia - prevention & control</subject><subject>bacteria</subject><subject>Bacterial Adhesion - drug effects</subject><subject>biofilm</subject><subject>Biofilms - drug effects</subject><subject>Biological and medical sciences</subject><subject>catheter lock</subject><subject>Catheterization</subject><subject>Catheters, Indwelling - adverse effects</subject><subject>Catheters, Indwelling - microbiology</subject><subject>Citrates - administration & dosage</subject><subject>Citrates - adverse effects</subject><subject>Citrates - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Edetic Acid - pharmacology</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Equipment Contamination - prevention & control</subject><subject>Gentamicins - administration & dosage</subject><subject>Heparin, Low-Molecular-Weight - pharmacology</subject><subject>Hirudins - pharmacology</subject><subject>Intensive care medicine</subject><subject>Kidneys</subject><subject>Medical sciences</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Pharmacology. Drug treatments</subject><subject>Polystyrenes</subject><subject>Polyurethanes</subject><subject>Recombinant Proteins - pharmacology</subject><subject>Silicone Elastomers</subject><subject>Solutions - pharmacology</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - growth & development</subject><subject>Staphylococcus epidermidis</subject><subject>Staphylococcus epidermidis - drug effects</subject><subject>Staphylococcus epidermidis - growth & development</subject><subject>Tissue Plasminogen Activator - pharmacology</subject><subject>Tumors of the urinary system</subject><issn>0931-0509</issn><issn>1460-2385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpd0F1rFDEUgOEgFrut3vgDZBDshTA2J5mcTC5l6YdQKhQV8SZksomdNjPZJhmw_96UXSwIgUDOwyG8hLwF-gmo4qfzppz-9gEkfUFW0CFtGe_FS7KqQ2ipoOqQHOV8RylVTMpX5BAQmUSKK_JjbcqtKy41Idr7JsewlDHOuRlnHxY3W9fkYra3j3UcrTWhGcboxzA1PqbJPNmmHlNfy2ibvCRvrMuvyYE3Ibs3-_uYfD8_-7a-bK--XnxZf75qrQBeWgsoGVcdRQRqOYJUvu8ZYqeYVWLTM4FSDFZ6icBwcEAHxjceuQPJe8OPyclu7zbFh8XloqcxWxeCmV1csgbFERWICt__B-_ikub6N82gB9EpxSr6uEM2xZyT83qbxsmkRw1UP6XWNbXepa743X7jMkxu80z3bSv4sAcm13A-mdmO-dn1lFfWVdfu3JiL-_NvbtK9Rsml0Jc_f-mb2uma30h9wf8CsPWVkQ</recordid><startdate>20060801</startdate><enddate>20060801</enddate><creator>Shanks, Robert M. Q.</creator><creator>Sargent, Jennifer L.</creator><creator>Martinez, Raquel M.</creator><creator>Graber, Martha L.</creator><creator>O'Toole, George A.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>20060801</creationdate><title>Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces</title><author>Shanks, Robert M. Q. ; Sargent, Jennifer L. ; Martinez, Raquel M. ; Graber, Martha L. ; O'Toole, George A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-c167239406610c36179f88266492c95d825675bc7f76126be10b23df63e1738a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>adherence</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>anticoagulant</topic><topic>Anticoagulants - administration & dosage</topic><topic>Anticoagulants - adverse effects</topic><topic>Anticoagulants - pharmacology</topic><topic>Bacteremia - etiology</topic><topic>Bacteremia - prevention & control</topic><topic>bacteria</topic><topic>Bacterial Adhesion - drug effects</topic><topic>biofilm</topic><topic>Biofilms - drug effects</topic><topic>Biological and medical sciences</topic><topic>catheter lock</topic><topic>Catheterization</topic><topic>Catheters, Indwelling - adverse effects</topic><topic>Catheters, Indwelling - microbiology</topic><topic>Citrates - administration & dosage</topic><topic>Citrates - adverse effects</topic><topic>Citrates - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Edetic Acid - pharmacology</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Equipment Contamination - prevention & control</topic><topic>Gentamicins - administration & dosage</topic><topic>Heparin, Low-Molecular-Weight - pharmacology</topic><topic>Hirudins - pharmacology</topic><topic>Intensive care medicine</topic><topic>Kidneys</topic><topic>Medical sciences</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Pharmacology. Drug treatments</topic><topic>Polystyrenes</topic><topic>Polyurethanes</topic><topic>Recombinant Proteins - pharmacology</topic><topic>Silicone Elastomers</topic><topic>Solutions - pharmacology</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - growth & development</topic><topic>Staphylococcus epidermidis</topic><topic>Staphylococcus epidermidis - drug effects</topic><topic>Staphylococcus epidermidis - growth & development</topic><topic>Tissue Plasminogen Activator - pharmacology</topic><topic>Tumors of the urinary system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shanks, Robert M. Q.</creatorcontrib><creatorcontrib>Sargent, Jennifer L.</creatorcontrib><creatorcontrib>Martinez, Raquel M.</creatorcontrib><creatorcontrib>Graber, Martha L.</creatorcontrib><creatorcontrib>O'Toole, George A.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Nephrology, dialysis, transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shanks, Robert M. Q.</au><au>Sargent, Jennifer L.</au><au>Martinez, Raquel M.</au><au>Graber, Martha L.</au><au>O'Toole, George A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces</atitle><jtitle>Nephrology, dialysis, transplantation</jtitle><addtitle>Nephrol. Dial. Transplant</addtitle><date>2006-08-01</date><risdate>2006</risdate><volume>21</volume><issue>8</issue><spage>2247</spage><epage>2255</epage><pages>2247-2255</pages><issn>0931-0509</issn><eissn>1460-2385</eissn><coden>NDTREA</coden><abstract>Background. Microbial biofilms form on central venous catheters and may be associated with systemic infections as well as decreased dialysis efficiency due to catheter thrombosis. The most widely used anticoagulant catheter lock solution in the US is sodium heparin. We have previously shown that sodium heparin in clinically relevant concentrations enhances Staphylococcus aureus biofilm formation. In the present study, we examine the effect of several alternative catheter lock solutions on in vitro biofilm formation by laboratory and clinical isolates of S. aureus and coagulase-negative staphylococci (CNS). Methods. Lepirudin, low molecular weight heparin, tissue plasminogen activator, sodium citrate, sodium citrate with gentamicin and sodium ethylene diamine tetra-acetic acid (EDTA) were assessed for their effect on biofilm formation on polystyrene, polyurethane and silicon elastomer. Results. Sodium citrate at concentrations above 0.5% efficiently inhibits biofilm formation and cell growth of S. aureus and Staphylococcus epidermidis. Subinhibitory concentrations of sodium citrate significantly stimulate biofilm formation in most tested S. aureus strains, but not in CNS strains. Sodium EDTA was effective in prevention of biofilm formation as was a combination of sodium citrate and gentamicin. Low molecular weight heparin stimulated biofilm formation of S. aureus, while lepirudin and tissue plasminogen activator had little effect on S. aureus biofilm formation. Conclusions. This in vitro study demonstrates that heparin alternatives, sodium citrate and sodium EDTA, can prevent the formation of S. aureus biofilms, suggesting that they may reduce the risk of biofilm-associated complications in indwelling catheters. This finding suggests a biological mechanism for the observed improvement in catheter-related outcomes in recent clinical comparisons of heparin and trisodium citrate as catheter locking solutions. A novel and potential clinically relevant finding of the present study is the observation that citrate at low levels strongly stimulates biofilm formation by S. aureus.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>16627606</pmid><doi>10.1093/ndt/gfl170</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0931-0509 |
ispartof | Nephrology, dialysis, transplantation, 2006-08, Vol.21 (8), p.2247-2255 |
issn | 0931-0509 1460-2385 |
language | eng |
recordid | cdi_proquest_miscellaneous_19366915 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | adherence Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents anticoagulant Anticoagulants - administration & dosage Anticoagulants - adverse effects Anticoagulants - pharmacology Bacteremia - etiology Bacteremia - prevention & control bacteria Bacterial Adhesion - drug effects biofilm Biofilms - drug effects Biological and medical sciences catheter lock Catheterization Catheters, Indwelling - adverse effects Catheters, Indwelling - microbiology Citrates - administration & dosage Citrates - adverse effects Citrates - pharmacology Dose-Response Relationship, Drug Edetic Acid - pharmacology Emergency and intensive care: renal failure. Dialysis management Equipment Contamination - prevention & control Gentamicins - administration & dosage Heparin, Low-Molecular-Weight - pharmacology Hirudins - pharmacology Intensive care medicine Kidneys Medical sciences Nephrology. Urinary tract diseases Pharmacology. Drug treatments Polystyrenes Polyurethanes Recombinant Proteins - pharmacology Silicone Elastomers Solutions - pharmacology Staphylococcus aureus Staphylococcus aureus - drug effects Staphylococcus aureus - growth & development Staphylococcus epidermidis Staphylococcus epidermidis - drug effects Staphylococcus epidermidis - growth & development Tissue Plasminogen Activator - pharmacology Tumors of the urinary system |
title | Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T17%3A44%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Catheter%20lock%20solutions%20influence%20staphylococcal%20biofilm%20formation%20on%20abiotic%20surfaces&rft.jtitle=Nephrology,%20dialysis,%20transplantation&rft.au=Shanks,%20Robert%20M.%20Q.&rft.date=2006-08-01&rft.volume=21&rft.issue=8&rft.spage=2247&rft.epage=2255&rft.pages=2247-2255&rft.issn=0931-0509&rft.eissn=1460-2385&rft.coden=NDTREA&rft_id=info:doi/10.1093/ndt/gfl170&rft_dat=%3Cproquest_cross%3E19366915%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=218154992&rft_id=info:pmid/16627606&rfr_iscdi=true |